Eswar Shankar - Search Results

Year	Number of Results
2004	1
2006	1
2007	1
2010	3
2011	2
2012	1
2013	2
2014	1
2015	3
2016	4
2017	3
2019	5
2020	7
2021	5
2022	3
2023	3
2024	1

1

Chamomile: A herbal medicine of the past with bright future.

Srivastava JK, Shankar E, Gupta S. Srivastava JK, et al. Among authors: shankar e. Mol Med Rep. 2010 Nov 1;3(6):895-901. doi: 10.3892/mmr.2010.377. Mol Med Rep. 2010. PMID: 21132119 Free PMC article.

2

EZH2-mediated development of therapeutic resistance in cancer.

Kaur P, Shankar E, Gupta S. Kaur P, et al. Among authors: shankar e. Cancer Lett. 2024 Apr 1;586:216706. doi: 10.1016/j.canlet.2024.216706. Epub 2024 Feb 7. Cancer Lett. 2024. PMID: 38331087 Review.

3

Editorial: Adopting drug repurposing to overcome drug resistance in cancer.

Shankar E, Subramaniam V, Allimuthu D. Shankar E, et al. Front Cell Dev Biol. 2023 Apr 28;11:1191682. doi: 10.3389/fcell.2023.1191682. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37187616 Free PMC article. No abstract available.

4

Statin Use in Prostate Cancer: An Update.

Babcook MA, Joshi A, Montellano JA, Shankar E, Gupta S. Babcook MA, et al. Among authors: shankar e. Nutr Metab Insights. 2016 Jul 14;9:43-50. doi: 10.4137/NMI.S38362. eCollection 2016. Nutr Metab Insights. 2016. PMID: 27441003 Free PMC article. Review.

5

Inhibition of Wnt/β-catenin pathway overcomes therapeutic resistance to abiraterone in castration-resistant prostate cancer.

Atawia IM, Kushwaha PP, Verma S, Lin S, Shankar E, Abdel-Gawad O, Gupta S. Atawia IM, et al. Among authors: shankar e. Mol Carcinog. 2023 Sep;62(9):1312-1324. doi: 10.1002/mc.23565. Epub 2023 May 26. Mol Carcinog. 2023. PMID: 37232341

6

Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

Shankar E, Kanwal R, Candamo M, Gupta S. Shankar E, et al. Semin Cancer Biol. 2016 Oct;40-41:82-99. doi: 10.1016/j.semcancer.2016.04.002. Epub 2016 Apr 23. Semin Cancer Biol. 2016. PMID: 27117759 Free PMC article. Review.

7

Plant flavone apigenin: An emerging anticancer agent.

Shankar E, Goel A, Gupta K, Gupta S. Shankar E, et al. Curr Pharmacol Rep. 2017 Dec;3(6):423-446. doi: 10.1007/s40495-017-0113-2. Epub 2017 Oct 14. Curr Pharmacol Rep. 2017. PMID: 29399439 Free PMC article.

8

Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy.

Verma S, Kushwaha PP, Shankar E, Ponsky LE, Gupta S. Verma S, et al. Among authors: shankar e. Prostate. 2022 Oct;82(14):1389-1399. doi: 10.1002/pros.24411. Epub 2022 Jul 12. Prostate. 2022. PMID: 35821621 Free PMC article.

9

PKCepsilon induces Bcl-2 by activating CREB.

Shankar E, Krishnamurthy S, Paranandi R, Basu A. Shankar E, et al. Int J Oncol. 2010 Apr;36(4):883-8. doi: 10.3892/ijo_00000566. Int J Oncol. 2010. PMID: 20198332

10

Novel approach to therapeutic targeting of castration-resistant prostate cancer.

Shankar E, Franco D, Iqbal O, El-Hayek V, Gupta S. Shankar E, et al. Med Hypotheses. 2020 Feb 19;140:109639. doi: 10.1016/j.mehy.2020.109639. Online ahead of print. Med Hypotheses. 2020. PMID: 32097843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year